Corticeira Amorim Reports 9M 2026 Financial Results
11/3/2026
Impact: -60
Healthcare
Corticeira Amorim reported a 4.3% decline in sales for the first nine months of 2026, citing lower volumes, an unfavorable product mix, and currency headwinds. Its EBITDA margin remained at 17.5%, while net debt fell to €56.0 million. The Amorim Cork Solutions business unit recorded sales growth and margin expansion.
AI summary, not financial advice
Share: